The Uterine Microbiome as a Biomarker for Endometrial Cancer
Posted 30th June 2017 by Jane Williams
Image credit: Hey Paul Studios, Flickr, licensed under CC BY 2.0
When asked about her team’s biggest success to date, Marina Walther-Antonio, a Mayo Clinic researcher, highlights the recently published study in Genome Medicine, identifying a unique vaginal microbiome for patients with endometrial cancer. This new discovery could lead to a biomarker for early detection and screening for the disease. It has led to similar research projects to study the impact of the microbiome on ovarian cancer.
Bacteria in a Bottle: Commercialising a Field in Development
Posted 23rd June 2017 by Jane Williams
The consumer products industry is built on well-established pillars. It’s a creative and dynamic industry with a clear playbook. While launching a brand or product is not trivial, this general rinse-repeat (pun intended) formula that the market leaders are able to leverage is a big part of why the consumer products industry among the largest on the planet and has continued to grow.
Innovative Research in Complementary and Alternative Medicines
Posted 2nd June 2017 by Jane Williams
Sydney, AU, Mon 13 FEB 2017; a television programme on the ABC aired a prime time expose on the Complementary and Alternative Medicines (CAM) industry, with the intent to discredit and warn consumers away from buying products that had no validated proof of working.
Presentation Slide Release: Skin Microbiota, Dysbiosis and Inflammation
Posted 26th May 2017 by Jane Williams
Everywhere you look, evidence points to the role of microbiomes in health. Since initial research on gut microbiota, focus has expanded to other sites of the human body. In particular, the skin microbiome has received much attention.
Here, we provide 3 sets of presentation slides centred around skin flora.
11 Lessons From Microbiome Research that Changed the way we Approach Microbes
Posted 15th May 2017 by Jane Williams
Written by Marcelline Goyen
Amsterdam was full of “international microbes” during the 4th Microbiome R&D and Business Collaboration Forum: Europe. More than 300 people interested in human microbiomes met at the Beurs van Berlage to listen to current research and meet colleagues and partners.
As an editor for Nederlands Tijdschrift voor Huidtherapie (NTVH), a Dutch magazine for Skin Therapy, and a skin therapist interested in the microbiome, I was lucky to be able to attend this meeting and I’d like to share with you some of the insights I gained.
The Human Microbiome in Focus: Probiotics, Modulation and Translation – Part 2
Posted 1st May 2017 by Jane Williams
The 4th Microbiome R&D and Business Collaboration Forum: Europe explored microbiota both inside and outside the gut and examined the role of the human microbiome in various diseases with a focus on modulation and biotherapeutic translation.
Last week, we published Duc H. Le’s summary of some of the presentations on day one. Here’s the second day summed up.
The Human Microbiome in Focus: Probiotics, Modulation and Translation – Part 1
Posted 24th April 2017 by Jane Williams
The 4th Microbiome R&D and Business Collaboration Forum: Europe explored microbiota both inside and outside the gut and examined the role of the human microbiome in various diseases with a focus on modulation and biotherapeutic translation.
Duc H. Le, UK Editor-in-Chief of EBioMedicine, summarises some of the presentations that took place on day one.
The Benefits of Whole Genome Sequencing for Microbiome Analysis
Posted 19th April 2017 by Jane Williams
Over the last decade, there has been a huge shift in the popular perception of microorganisms – instead of considering them as potentially pathogenic organisms that should be destroyed, we now realise that the microorganisms living in and on us are an essential part of us and necessary for good health.